Neprilysin expression and functions in development, ageing and disease
NN Nalivaeva, IA Zhuravin, AJ Turner - Mechanisms of ageing and …, 2020 - Elsevier
Neprilysin (NEP) is an integral membrane-bound metallopeptidase with a wide spectrum of
substrates and physiological functions. It plays an important role in proteolytic processes in …
substrates and physiological functions. It plays an important role in proteolytic processes in …
Recent advances in the modeling of Alzheimer's disease
H Sasaguri, S Hashimoto, N Watamura… - Frontiers in …, 2022 - frontiersin.org
Since 1995, more than 100 transgenic (Tg) mouse models of Alzheimer's disease (AD) have
been generated in which mutant amyloid precursor protein (APP) or APP/presenilin 1 (PS1) …
been generated in which mutant amyloid precursor protein (APP) or APP/presenilin 1 (PS1) …
Therapeutics of Alzheimer's disease: Past, present and future
Alzheimer's disease (AD) is the most common cause of dementia worldwide. The etiology is
multifactorial, and pathophysiology of the disease is complex. Data indicate an exponential …
multifactorial, and pathophysiology of the disease is complex. Data indicate an exponential …
International Union of Basic and Clinical Pharmacology. CV. Somatostatin receptors: structure, function, ligands, and new nomenclature
T Günther, G Tulipano, P Dournaud, C Bousquet… - Pharmacological …, 2018 - ASPET
Somatostatin, also known as somatotropin-release inhibitory factor, is a cyclopeptide that
exerts potent inhibitory actions on hormone secretion and neuronal excitability. Its …
exerts potent inhibitory actions on hormone secretion and neuronal excitability. Its …
Molecular evidence for BDNF-and GABA-related dysfunctions in the amygdala of female subjects with major depression
JP Guilloux, G Douillard-Guilloux, R Kota, X Wang… - Molecular …, 2012 - nature.com
Women are twice as likely as men to develop major depressive disorder (MDD) and are
more prone to recurring episodes. Hence, we tested the hypothesis that the illness may …
more prone to recurring episodes. Hence, we tested the hypothesis that the illness may …
Aβ-degrading enzymes: potential for treatment of Alzheimer disease
There is increasing evidence that deficient clearance of β-amyloid (Aβ) contributes to its
accumulation in late-onset Alzheimer disease (AD). Several Aβ-degrading enzymes …
accumulation in late-onset Alzheimer disease (AD). Several Aβ-degrading enzymes …
Neprilysin and Aβ clearance: impact of the APP intracellular domain in NEP regulation and implications in Alzheimer's disease
MOW Grimm, J Mett, CP Stahlmann… - Frontiers in aging …, 2013 - frontiersin.org
One of the characteristic hallmarks of Alzheimer's disease (AD) is an accumulation of
amyloid β (Aβ) leading to plaque formation and toxic oligomeric Aβ complexes. Besides the …
amyloid β (Aβ) leading to plaque formation and toxic oligomeric Aβ complexes. Besides the …
Gi/o-Protein Coupled Receptors in the Aging Brain
PG de Oliveira, MLS Ramos, AJ Amaro… - Frontiers in aging …, 2019 - frontiersin.org
Cells translate extracellular signals to regulate processes such as differentiation,
metabolism and proliferation, via transmembranar receptors. G protein-coupled receptors …
metabolism and proliferation, via transmembranar receptors. G protein-coupled receptors …
Neuropeptides in learning and memory
É Borbély, B Scheich, Z Helyes - Neuropeptides, 2013 - Elsevier
Dementia conditions and memory deficits of different origins (vascular, metabolic and
primary neurodegenerative such as Alzheimer's and Parkinson's diseases) are getting more …
primary neurodegenerative such as Alzheimer's and Parkinson's diseases) are getting more …
Aging biomarkers and the brain
Quantifying biological aging is critical for understanding why aging is the primary driver of
morbidity and mortality and for assessing novel therapies to counter pathological aging. In …
morbidity and mortality and for assessing novel therapies to counter pathological aging. In …